Stock Yearly Return 2017
Start date: 01/03/2017
End date: 12/29/2017
Start price/share: $17.85
End price/share: $14.00
Starting shares: 560.22
Ending shares: 580.92
Dividends reinvested/share: $0.50
Total return: -18.67%
VIVO Average Annual Return: -18.93%
Starting investment: $10,000.00
Ending investment: $8,133.00


VIVO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare VIVO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
With Dividends Reinvested Into VIVO


Also see:
VIVO stock yearly return 2018
VIVO stock yearly return 2019
VIVO stock yearly return 2020
VIVO YTD return
VIVO average annual return 10 years
Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic test kits, primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media products; and Life Science. The VIVO stock yearly return is shown above.

The yearly return on the VIVO stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2017 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the VIVO annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for VIVO:
VIVO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Meridian Bioscience (VIVO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

VKTX Average Annual Return
VLRX Average Annual Return
VNDA Average Annual Return
VRAY Average Annual Return
VRML Average Annual Return
VRTX Average Annual Return
VRX Average Annual Return
VSAR Average Annual Return
VSTM Average Annual Return
VTGN Average Annual Return
More Healthcare companies »

 

VIVO Stock Yearly Return 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.